Where the Evidence Actually Sits

Nearly every landmark trial used intravenous administration: Berman, Zarate, Murrough, Feder, the chronic pain consensus guidelines. Sublingual dosing is supported more by clinical experience and smaller studies than by that body of randomized work. Sites offering at-home ketamine routinely cite the infusion literature without flagging the route difference, and that is a real gap rather than a technicality.

• The reference efficacy trials used intravenous administration
• The chronic pain consensus guidelines describe infusion protocols specifically
• Sublingual has a thinner randomized evidence base
• Route affects bioavailability, metabolite profile and dose precision
• Citing infusion data to sell sublingual borrows credibility from another route

What Infusion Does Better

Intravenous administration gives complete bioavailability and precise control: the dose is titratable in real time and can be stopped mid-session, which sublingual cannot. Continuous monitoring means blood pressure is watched rather than estimated, and staff can intervene physically. For medically complex patients, severe presentations, or anyone whose response needs close observation, those are decisive advantages.

• Complete bioavailability with no first-pass variability
• Dose titratable during the session and stoppable if needed
• Continuous cardiovascular monitoring by trained staff
• Physical intervention available if something goes wrong
• The route the strongest evidence was generated with

What At-Home Does Better

The advantages are practical rather than pharmacological, and they matter more than that framing suggests, because a treatment you cannot sustain is not a treatment. Infusion courses commonly run several thousand dollars for an initial series before maintenance, plus travel and a driver for each visit. Patients frequently complete an initial infusion series and then stop, not because it failed but because the logistics were unsustainable.

• Substantially lower cost across a full course
• No travel, no clinic waiting room, no driver needed each visit
• Familiar environment, which some patients find genuinely better for set and setting
• Easier to sustain maintenance dosing over months
• Extended booking windows including 12:30 PM and 5:00 PM appointments

How the Experience Differs

These are not the same experience at a different price. Infusion arrives faster and peaks harder; sublingual comes on over ten to twenty minutes with a gentler peak. Neither is better in itself, and patients differ in which they tolerate. Anxious patients often prefer the slower onset; patients who want the session finished efficiently often prefer infusion.

• Infusion onset is rapid; sublingual builds over ten to twenty minutes
• Peak intensity is generally higher with intravenous administration
• Sublingual absorption varies with technique and saliva
• Nausea is more commonly reported with the sublingual route
• Anxious patients frequently prefer the gentler sublingual onset

Which One to Choose

The decision usually follows from the presentation rather than from preference. We refer patients to infusion clinics regularly, and if that is the better fit for you it is what you will hear at the consultation.

• Choose infusion for chronic pain as the primary complaint, where the guidelines are
• Choose infusion for medically complex cases needing continuous monitoring
• Choose infusion if no sober support person can be present at home
• Choose at-home for treatment-resistant depression where cost or travel is the barrier
• Choose at-home when maintenance over months is the realistic requirement